Your browser doesn't support javascript.
loading
Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease.
Gould, K Lance; Johnson, Nils P; Roby, Amanda E; Nguyen, Tung; Kirkeeide, Richard; Haynie, Mary; Lai, Dejian; Zhu, Hongjian; Patel, Monica B; Smalling, Richard; Arain, Sal; Balan, Prakash; Nguyen, Tom; Estrera, Anthony; Sdringola, Stefano; Madjid, Mohammad; Nascimbene, Angelo; Loyalka, Pranav; Kar, Biswajit; Gregoric, Igor; Safi, Hazem; McPherson, David.
Affiliation
  • Gould KL; Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas k.lance.gould@uth.tmc.edu.
  • Johnson NP; Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
  • Roby AE; Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
  • Nguyen T; Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
  • Kirkeeide R; Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
  • Haynie M; Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
  • Lai D; Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center, Houston Texas.
  • Zhu H; Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center, Houston Texas.
  • Patel MB; Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
  • Smalling R; Division of Cardiology, Department of Medicine, McGovern Medial Medical School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
  • Arain S; Division of Cardiology, Department of Medicine, McGovern Medial Medical School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
  • Balan P; Division of Cardiology, Department of Medicine, McGovern Medial Medical School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
  • Nguyen T; Department of Cardiothoracic Vascular Surgery, McGovern Medial School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas; and.
  • Estrera A; Department of Cardiothoracic Vascular Surgery, McGovern Medial School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas; and.
  • Sdringola S; Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
  • Madjid M; Division of Cardiology, Department of Medicine, McGovern Medical School, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
  • Nascimbene A; Department of Advanced Cardiopulmonary Therapies and Transplantation, McGovern Medical School, University of Texas Health Science Center at Houston and Memorial Hermann Hospital, Houston, Texas.
  • Loyalka P; Department of Advanced Cardiopulmonary Therapies and Transplantation, McGovern Medical School, University of Texas Health Science Center at Houston and Memorial Hermann Hospital, Houston, Texas.
  • Kar B; Department of Advanced Cardiopulmonary Therapies and Transplantation, McGovern Medical School, University of Texas Health Science Center at Houston and Memorial Hermann Hospital, Houston, Texas.
  • Gregoric I; Department of Advanced Cardiopulmonary Therapies and Transplantation, McGovern Medical School, University of Texas Health Science Center at Houston and Memorial Hermann Hospital, Houston, Texas.
  • Safi H; Department of Cardiothoracic Vascular Surgery, McGovern Medial School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas; and.
  • McPherson D; Division of Cardiology, Department of Medicine, McGovern Medial Medical School, University of Texas Health Science Center and Memorial Hermann Hospital, Houston, Texas.
J Nucl Med ; 60(3): 410-417, 2019 03.
Article in En | MEDLINE | ID: mdl-30115688
Because randomized coronary revascularization trials in stable coronary artery disease (CAD) have shown no reduced myocardial infarction (MI) or mortality, the threshold of quantitative myocardial perfusion severity was analyzed for association with reduced death, MI, or stroke after revascularization within 90 d after PET. Methods: In a prospective long-term cohort of stable CAD, regional, artery-specific, quantitative myocardial perfusion by PET, coronary revascularization within 90 d after PET, and all-cause death, MI, and stroke (DMS) at 9-y follow-up (mean ± SD, 3.0 ± 2.3 y) were analyzed by multivariate Cox regression models and propensity analysis. Results: For 3,774 sequential rest-stress PET scans, regional, artery-specific, severely reduced coronary flow capacity (CFC) (coronary flow reserve ≤ 1.27 and stress perfusion ≤ 0.83 cc/min/g) associated with 60% increased hazard ratio for major adverse cardiovascular events and 30% increased hazard of DMS that was significantly reduced by 54% associated with revascularization within 90 d after PET (P = 0.0369), compared with moderate or mild CFC, coronary flow reserve, other PET metrics or medical treatment alone. Depending on severity threshold for statistical certainty, up to 19% of this clinical cohort had CFC severity associated with reduced DMS after revascularization. Conclusion: CFC by PET provides objective, regional, artery-specific, size-severity physiologic quantification of CAD severity associated with high risk of DMS that is significantly reduced after revascularization within 90 d after PET, an association not seen for moderate to mild perfusion abnormalities or medical treatment alone.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arteries / Coronary Artery Disease / Coronary Circulation / Positron-Emission Tomography / Myocardial Infarction / Myocardial Revascularization Type of study: Clinical_trials / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: J Nucl Med Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arteries / Coronary Artery Disease / Coronary Circulation / Positron-Emission Tomography / Myocardial Infarction / Myocardial Revascularization Type of study: Clinical_trials / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: J Nucl Med Year: 2019 Type: Article